The share price has dropped but as mentioned before the fundamentals haven't changed. If I had spare cash I'd definitely be topping up at these levels.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025